سعر ابيليفاي مينتينا Abilify Maintena‏ 300 مجم حقنة جاهزة عضلية 2026

Long-acting injectable aripiprazole 300 mg pre-filled syringe for monthly IM maintenance treatment of schizophrenia.

• Hypersensitivity to aripiprazole or to any of the excipients.International label, same formulation · European Medicines Agency (EPAR product information)

• Neuroleptic malignant syndrome and tardive dyskinesia can occur with antipsychotics.International label, same formulation · European Medicines Agency (EPAR product information)

• CYP2D6 poor metabolisers / strong CYP2D6 or CYP3A4 inhibitorsDose adjustments are required (e.g. 300 mg in known CYP2D6 poor metabolisers) as specified in the SmPC.European Medicines Agency (EPAR product information)

• Should not be used during pregnancy unless clearly necessary; exposure may persist for up to 34 weeks after a dose.International label, same formulation · European Medicines Agency (EPAR product information)
• Breastfeeding should be avoided in patients treated within the past 34 weeks.International label, same formulation · European Medicines Agency (EPAR product information)

• Aripiprazole: Mechanism in schizophrenia and bipolar I disorder is not fully known; efficacy may be mediated by partial agonism at dopamine D2 and serotonin 5-HT1A receptors combined with antagonism at 5-HT2A receptors (US prescribing information).